Evaluating TG Therapeutics: Insights From 4 Financial Analysts
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
评估TG Therapeutics：来自4位财务分析师的见解
A clear picture of TG Therapeutics's perception among financial...During the last three months, 4 analysts shared their evaluations of TG Therapeutics (NASDAQ:TGTX), revealing diverse outlooks from bullish to bearish.
在过去的三个月里，有4位分析师对TG Therapeutics (纳斯达克:TGTX)进行了评估，显示出从看好到看淡的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.0, a high estimate of $49.00, and a low estimate of $20.00. Observing a 4.83% increase, the current average has risen from the previous average price target of $36.25.
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.0, a high estimate of $49.00, and a low estimate of $20.00. Observing a 4.83% increase, the current average has risen from the previous average price target of $36.25.
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
A clear picture of TG Therapeutics's perception among financial...
通过对最近分析师行动...
登录免费看全文
登录/注册
资讯热榜
更新时间